Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium Effect on Physical Activity in COPD
NCT00144326Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2003
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Tiotropium with Placebo (2 arms). Primary endpoint: Difference in physical activity measured in vector magnitude units (VMUs) at 12 weeks. Started Jul 2003; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00144326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00144326.